WebOct 13, 2024 · BOSTON, October 13, 2024 — Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, M.D., as Chief Executive Officer and member of the Board of Directors. “We are extremely fortunate to … WebApr 11, 2024 · 与此同时,其竞争对手之一,Dewpoint Therapeutics已经与辉瑞、拜耳和默克公司签署了协议。 4月初刚刚关闭的Vedere Bio II则是一家两年前创立的开发眼部基因疗法的公司。公司的两位领导人在 LinkedIn上发布消息称,Vedere将在收到令人失望的临床前数 …
Dewpoint Therapeutics partners with Novo Nordisk to explore …
WebOct 13, 2024 · New technological development is helping scientists recreate condensates in laboratory conditions, providing insight into fundamental cellular processes. Amir Nashat, CEO of Dewpoint Therapeutics, told In Vivo that the company, following a recent $77m series B round, now has the resources to get to proof of concept for drugs targeting ... WebDec 20, 2024 · Dewpoint scientists work in Boston, Dresden, and Berlin to translate condensate biology into treatments for the toughest diseases. Learn more at … east german embassy washington dc
Chief Executive Officer – Dewpoint Therapeutics - LinkedIn
WebMar 23, 2024 · They said the same thing: Dewpoint Therapeutics." Young brokered a meeting between Nathwani and Uli Stilz, the Boston-based vice president of Novo Nordisk. The two companies found a deal. WebVolastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment NEW YORK and BOSTON, March 9, 2024 /PRNewswire/ -- Volastra Therapeutics and Dewpoint Therapeutics today announced a research and development partnership to discover novel modulators of biomolecular condensates to … WebChief Scientific Officer. Apr 2024 - Present2 years 1 month. Boston, Massachusetts, United States. I am part of an international Research … east german dictatorship